Articles tagged with Covid 19 Vaccines
Researchers at La Jolla Institute for Immunology found that most T cells can still target epitopes on the new Pirola variant, suggesting people may be able to mount a response against it. The study's findings provide positive news in the fight against SARS-CoV-2, emphasizing the importance of vaccination with updated vaccines.
A study by Sean O’Leary and colleagues found that COVID-19 vaccine hesitancy remained stable in Colorado, but parental trust vacillated during the pandemic. The researchers used a validated survey to track vaccine attitudes of parents, revealing trends indicating that misinformation has affected parental trust in childhood vaccines.
Researchers have identified a sequence within therapeutic mRNAs that causes unintended immune responses and found a way to correct these errors. By designing 'slip-resistant' mRNAs, the team aims to produce future mRNA vaccines with improved safety and efficacy.
Researchers found that vaccination increases immune cell production and antibody levels effective against all tested variants of SARS-CoV-2, including Omicron. Convalescent plasma therapy research provides insight into how the body fights COVID-19 variants.
A new study reveals that threats against public health workers increased and changed in nature during the COVID-19 pandemic, affecting nearly half of local health directors and leading to increased turnover and burnout. The study calls for expanded legal protections and resilience training for the public health workforce.
Researchers found a strong preference for extroverted virtual assistants and increasing personality similarity led to higher ratings, more careful assessment of information, and resistance to persuasive attempts. The study's findings may have implications for ways to increase user resistance to misinformation.
Researchers assessed Veterans Affairs participants' coping strategies over three timepoints, finding that stable coping styles are associated with lower levels of anxiety and depression. The majority of the sample (71%) changed their coping style at least once during the study period.
A new Stanford University study found that COVID-19 vaccination during pregnancy lowered the risk of preterm birth. The research analyzed natality data from California and found a significant reduction in preterm births among vaccinated mothers compared to unvaccinated ones.
A recent study found that COVID-19 transmission rates in child care centers were only about 2% to 3%, with 1 in 20 symptomatic children testing positive. Vaccination is still highly recommended, as vaccines are a safe and effective way of preventing serious infection.
Researchers developed a practice facilitation program to support family physicians in identifying unvaccinated patients and addressing vaccine hesitancy. The intervention provided resources such as scripts and medical student volunteers to work as physician-delegates, resulting in improved vaccination rates.
A new study found that COVID-19 caused a significant spike in premature births, but vaccines played a crucial role in reducing the risk of preterm birth to pre-pandemic levels. The research analyzed California birth records and found that maternal COVID infection increased the risk of preterm births by 1.2 percentage points.
A new study found that a half-dose of the Pfizer COVID-19 booster vaccine elicited a non-inferior immune response to a full dose in Mongolian adults, with fewer side effects. The study suggests that fractional dosing may improve booster acceptability and reduce costs.
A study found that cancer patients with COVID-19 had significantly higher mortality and hospitalization rates compared to non-cancer patients, highlighting the increased risk of severe illness. COVID-19 vaccination in cancer patients reduced this risk, emphasizing the importance of vaccination in protecting vulnerable populations.
A new study suggests that a fourth dose of the mRNA vaccine significantly reduces risk of infection and severe COVID-19 in patients with autoimmune rheumatic diseases. The study found a 41% reduction in risk for infection and 65% reduction for admission/death compared to those who did not receive a fourth dose.
Two COVID-19 studies on Singapore mothers and children found vaccination during pregnancy reduces newborn infection risk by up to 44.4%. Vaccination also showed potential protection against Long COVID in children under 18, with males more likely to experience symptoms.
A study found that 20% of patients treated with nirmatrelvir-ritavir (N-R) experienced virologic rebound, a phenomenon where viral load increases after initial decline. In contrast, only 1 untreated patient was affected. The researchers suggest considering the risks and benefits of N-R treatment in patients at low risk for severe disease.
An mRNA SARS-CoV-2 vaccination before vs. during pregnancy and omicron infection among infants study found that maternal vaccination during the antenatal period was associated with a lower risk of Omicron SARS-CoV-2 infection in infants up to six months of age.
A recent study published in eClinical Medicine found that the GB510/AS03 vaccine elicited a stronger antibody immune response against the ancestral SARS-CoV-2 strain compared to ChAdOx1-S. The vaccine demonstrated robust safety and efficacy, with no significant safety concerns identified.
The study found co-administration of the Pfizer-BioNTech COVID-19 vaccine with the seasonal influenza vaccine to be effective in preventing COVID-19 and flu-related outcomes. This may improve vaccination uptake for both vaccines.
A meta-analysis of studies found guilt has only a small persuasive effect, making it less effective than previously thought. Existential guilt appeals better for broader issues like environmental and educational topics, while personal responsibility-based guilt is less effective in health communications.
A study by the University of Plymouth and Nottingham Trent University found that reading and writing poetry had a substantial positive impact on participants' wellbeing during the pandemic. Poetry helped reduce feelings of loneliness, anxiety, and depression, as well as supporting social and cultural recovery.
A team of University of Maryland researchers developed a nasal spray vaccine that delivers the SARS-CoV-2 spike protein into cells of the airway, triggering an immune response that significantly reduced infection and spread of COVID-19. The technology can be adapted to induce immunity to other respiratory illnesses.
A University of Michigan team found that vaccinating people over 65 against COVID-19 will save the US money, while younger adults may not see significant cost savings. The analysis, commissioned by the CDC, focused on costs to insurers and the government.
A new study by Boston University School of Public Health found that COVID-19 vaccination in female and male partners does not increase the risk of miscarriage. In fact, vaccinated individuals had a slightly lower risk of miscarriage compared to unvaccinated individuals. The study analyzed survey data from over 1,800 female participants...
Scientists at the University of Birmingham have identified a mechanism that led to some patients experiencing deadly clotting following Covid-19 vaccination. The team found that Platelet factor 4 (PF4) activates the c-Mpl-Jak2 pathway in platelets, triggering clot formation.
A new study found that while most residents in British Columbia had been infected with SARS-CoV-2, older adults remained at highest risk of hospitalization and death due to COVID-19. The researchers estimated that the risk of hospitalization for COVID-19 was about 1 in 30 among adults 80 years and older.
A study found that COVID-19 transmission rates in child care centers were low, with only 2% to 3% of cases occurring within the centers. In contrast, household transmission was high, with 50% of children and 67% of adults contracting the virus once infected.
A study of 83 children in 11 child care centers found low SARS-CoV-2 incidence and transmission within the centers, as well as from infected children to households
A new model predicts the evolution of SARS-CoV-2 variants by analyzing massive data on infections and vaccinations. Human immunity now drives the virus's evolution, with continued surveillance crucial to inform future vaccines.
A study of 142,000 live births found that maternal mRNA COVID-19 vaccination during pregnancy was associated with reduced risks of severe neonatal morbidity, neonatal death, and intensive care unit admission. No increase in hospital admissions or readmissions up to age six months was observed.
A new study published in JAMA Pediatrics found that infants born to mothers who received an mRNA COVID-19 vaccine during pregnancy had lower risks of severe health outcomes, neonatal death, and NICU admission. The study also showed no increase in newborn and six-month readmissions to the NICU.
Researchers identified enhanced B-cell and T-cell responses in fully vaccinated individuals who became infected with SARS-CoV-2, generating immunological memory to prevent severe infection. Vaccine-primed memory T cells play a critical role in preventing severe COVID-19.
A recent study in JAMA Network Open explores COVID-19 vaccine refusal and willingness, highlighting trust in health authorities as a crucial factor. The research suggests that building trust in healthcare professionals, experts, and public health agencies is essential for overcoming pandemic-related vaccine hesitancy.
A study by UC Riverside researchers found that communities of color in Inland Southern California experienced fear and mistrust of institutions due to historical, cultural, and social traumas. The study highlights the need for culturally sensitive health interventions to address these traumas and promote community-based approaches for ...
Researchers at Duke University Medical Center have developed a single nanoparticle vaccine that protects against SARS-CoV-1 and MERS coronaviruses in addition to SARS-CoV-2.
A primary mRNA vaccine series offers significant protection against SARS-CoV-2 infection in Singaporean children aged 1-4. The study found a low incidence of hospitalization and severe illness, but highlights the potential benefits of vaccination in preventing infection and sequelae.
Research found that young children's immune systems produce protective antibodies at high levels for up to 300 days after infection. Unlike adults, children have high levels of inflammatory cytokines in their noses but not in their blood, potentially explaining the mildness of COVID-19 in this age group.
A new AI tool named EVEscape can predict future viral variants of concern, potentially helping scientists develop more effective vaccines and therapies. The tool uses evolutionary and biological information to forecast which mutations will occur in viruses like SARS-CoV-2.
A recent study published in the Journal of Clinical Investigation found that coronavirus vaccines build immune memory in various organs, including the liver, kidneys, and lungs. This local immune response is more effective than circulating antibodies in protecting against infection.
Researchers found a quantitative difference in B cell response following vaccination between young and older adults, with younger adults mounting a stronger clonal response and older adults having more activated B cells. This study provides insights into the age-related differences in B cell vaccine response and may lead to the develop...
A study by National Jewish Health found that nearly half of patients with underlying lung conditions have lower vaccine-specific antibody, B cell, and T cell responses compared to healthy individuals. This decreased immunity suggests patients with lung conditions may be less protected against COVID-19.
A Singaporean study found that unvaccinated COVID-19 survivors are at a heightened risk of heart complications almost a year after recovery. The study revealed a 56% higher risk of developing new heart complications among unvaccinated survivors compared to uninfected individuals.
A new study reveals that immunity to SARS-CoV-2 variants depends on previous exposure and vaccination history. The research found significant differences in immune responses to various variants, highlighting the need for personalized vaccine approaches.
Research published in European Journal of Neurology indicates that COVID-19 and COVID-19 vaccination have negligible effects on migraine severity. Among participants who reported worsening migraines, those infected were 2.5-times more likely to be concerned about migraine worsening than those vaccinated.
Researchers found that antigen testing significantly reduces the probability of cluster occurrence by identifying and isolating infected persons. However, it may not be effective against highly infectious mutant strains like Omicron, highlighting the need for booster vaccination campaigns and other infection control measures.
Researchers developed a new base modification, Z-mRNA, that demonstrates low immunogenicity and reduced cytotoxicity compared to unmodified mRNAs. The modified mRNA can induce a substantial immune response and has potential therapeutic applications beyond COVID-19 vaccines.
Researchers found that using electronic prompts during appointment scheduling for seasonal flu and COVID-19 vaccines can identify willing participants for HPV and shingles vaccines. Only 30% of those booking for these vaccines were already vaccinated against HPV, presenting a significant opportunity for targeted campaigns.
A new study found that nearly 40% of eligible adults did not receive a COVID-19 booster due to prior infection with SARS-CoV-2 or concerns about vaccine side effects. The researchers hope the findings can inform design of interventions to improve vaccination rates.
Scientists have developed a trivalent vaccine candidate that provides broad and long-lasting protection against COVID-19 infection by delivering the vaccine via the nose. The vaccine triggers a strong neutralizing antibody response and protects mucosal areas, preventing disease symptoms.
The article discusses the need to reassess COVID-19 precautions in 2023, particularly for patients with hematologic malignancies. The researchers highlight the increased risk of poor response to vaccination and worse outcomes from COVID-19 infection among these patients.
Researchers identified two SARS-CoV-2 protein mutations linked to severe COVID-19 symptoms and increased inflammation. The mutations, known as KR, were found in patients with higher viral loads and more severe symptoms.
A new vaccine candidate has shown protection against a range of coronaviruses, including current and future variants, by targeting the critical regions of the virus that it needs to complete its life cycle. The vaccine technology, developed at the University of Cambridge, aims to provide broad-based protection against emerging viruses.
Pregnant women are urged to get vaccinated against COVID-19 to protect themselves and their babies. A new study suggests that COVID-19 vaccines and boosters can significantly improve maternal-fetal outcomes.
A study of 68,000 patients with COVID-19 found that using Paxlovid or Lagevrio significantly reduced mortality and hospitalization rates in those at high risk of progressing to severe COVID-19, regardless of age, race, or virus strain. These medications can be used to treat non-hospitalized patients at high risk of severe disease.
Researchers at Cleveland Clinic have developed a potential vaccine candidate against Dabie Bandavirus using nanoparticles, which can deliver antigens at a lower dose with fewer side effects. The vaccine has shown promise in pre-clinical studies and could provide protection to adults over 50, who are most vulnerable to the virus.
A study has identified key T cell subsets that track closely with successful vaccination and are responsible for early protection against SARS-CoV-2. The research found distinct CD8+ T cells that proliferate and attack key proteins of the pandemic virus, particularly those lacking surface protein KLRG1.
The American Thoracic Society has partnered with five new health systems to identify barriers to vaccination and find ways to improve immunization rates. The initiative aims to increase COVID-19, flu, and pneumonia vaccine uptake among high-risk adults with respiratory diseases.
The American College of Physicians has issued updated rapid, living practice points on treating COVID-19 patients in outpatient settings. The new guidance supports the use of molnupiravir or nirmatrelvir-ritonavir for symptomatic patients with confirmed mild to moderate COVID-19.
A large-scale study analyzing data from 197 million people has generated background incidence rates on conditions such as myocarditis, pulmonary embolism, and Guillain-Barré syndrome for COVID-19 vaccine safety monitoring. The findings provide important data for investigating reports of medical events following vaccination.
Receiving two doses of BNT162b2 vaccine was associated with lower risk of COVID-19 emergency department and outpatient visits. The risk appeared lower for those with two versus three doses, despite Omicron sublineages becoming dominant.